What is the Impact of Rheumatoid Factor Positivity on the Real-world Effectiveness of Infliximab Treatment in Rheumatoid Arthritis?

被引：0
|
作者：
Choquette, Denis [1 ]
Faraawi, Rafat
Zummer, Michel [2 ]
Chow, Andrew [3 ]
Kelsall, John [4 ,5 ]
Rampakakis, Emmanouil [6 ,7 ]
Sampalis, John [8 ,9 ]
Otawa, Susan [10 ]
Lehman, Allen [10 ]
Shawl, May [10 ]
机构：
[1] Hop Notre Dame de Bon Secours, Montreal, PQ H2L 4K8, Canada
[2] CH Maisonneuve Rosemont, Montreal, PQ, Canada
[3] Univ Toronto, McMaster Univ, Credit Valley Rheumatol, Mississauga, ON L5L 1C6, Canada
[4] Univ British Columbia, Mary Pack Arthrit Ctr, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Div Rheumatol, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada
[6] JSS Med Res, St Laurent, PQ, Canada
[7] McGill Univ, St Laurent, PQ, Canada
[8] McGill Univ, Westmount, PQ, Canada
[9] Univ Montreal, Westmount, PQ, Canada
[10] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2013年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
30
引用
收藏
页码：965 / 965
页数：1
相关论文
共 50 条
  • [41] Infliximab treatment of rheumatoid arthritis
    Maini, R
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 329 - +
  • [42] Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data
    Edwards, Christoper J.
    Takeuchi, Tsutomu
    Finckh, Axel
    Kleyer, Arnd
    Haladyj, Ewa
    Gerwien, Jens Gammeltoft
    Treuer, Tamas
    Zaremba-Pechmann, Liliana
    Smolen, Josef S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (11) : 1993 - 2002
  • [43] Treatment of rheumatoid arthritis with infliximab
    Schwebig, A
    Thriene, W
    AKTUELLE RHEUMATOLOGIE, 2000, 25 (03) : 93 - 96
  • [44] Infliximab in the treatment of rheumatoid arthritis
    Perdriger, A.
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 183 - 191
  • [45] WHAT IS THE TREATMENT DURABILITY AND SAFETY PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB PLUS METHOTREXATE AND/OR LEFLUNOMIDE? AN ANALYSIS FROM A REAL-WORLD REGISTRY
    Faraawi, R.
    Joshi, R.
    Bensen, W.
    Choquette, D.
    Olszynski, W.
    Arendse, R.
    Sheriff, M.
    Rahman, P.
    Sampalis, J.
    Rampakakis, E.
    Tkaczyk, C.
    Nantel, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 714 - 714
  • [46] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? an Analysis from a Real-World Registry
    Faraawi, Rafat
    Joshi, Raman
    Bensen, William G.
    Choquette, Denis
    Olsynzynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Tkaczyk, Cathy
    Osborne, Brendan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] Real-world switching and discontinuation outcomes of infliximab biosimilars in patients with rheumatoid arthritis: A scoping review
    Yin, Yue
    McDermott, Cara
    Lockhart, Catherine
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (09): : 985 - 998
  • [48] OUTCOMES WITH INFLIXIMAB AND ITS BIOSIMILARS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): REAL-WORLD EXPERIENCE IN THE US
    Helfgott, S. M.
    Radtchenko, J.
    Soloman, N.
    Huston, K.
    Singh, J. A.
    Edgerton, C.
    VALUE IN HEALTH, 2021, 24 : S14 - S15
  • [49] REAL-WORLD COMPARATIVE EFFECTIVENESS OF ADALIMUMAB AND TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: RESULTS OF AN ADMINISTRATIVE CLAIMS ANALYSIS
    Garg, V.
    Griffith, J.
    Hayes, O. A.
    Bao, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 357 - 357
  • [50] Real-world effectiveness and safety of rituximab in the treatment of rheumatoid arthritis: A single-center experience in Taiwan
    Wang, Kai-Chun
    Liao, Hsien-Tzung
    Chen, Wei-Sheng
    Lai, Chien-Chih
    Chou, Chung-Tei
    Chen, Ming-Han
    Tsai, Chang-Youh
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (05) : 860 - 868
12345